Cipla files defensive patent suit over Ofev generic

Mumbai-based pharma company Cipla has filed a lawsuit asking a Delaware court to rule that its proposed generic of Boehringer Ingelheim’s lung disease treatment Ofev (Nintedanib) does not infringe two patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Teva sues Cipla over generic asthma inhalers

11 August 2020 Israeli drug manufacturer Teva Pharmaceuticals is suing India-based Cipla to block the launch of generic Qvar asthma inhalers.

Americas

Astellas accuses Cipla of infringing overactive bladder patent

7 June 2018 Pharmaceutical company Astellas Pharma has filed a patent infringement claim against India-based Cipla over a drug for treating an overactive bladder.

Big Pharma

Cipla loses fightback over diarrhoea antibiotic

25 April 2023 Judge rejects notion that tribunal acted unfairly in royalties dispute with Salix | Indian firm wanted payments on sales of antibiotic | Appeal brought under act with ‘high hurdle to surmount’.

More on this story

Americas

Teva sues Cipla over generic asthma inhalers

11 August 2020 Israeli drug manufacturer Teva Pharmaceuticals is suing India-based Cipla to block the launch of generic Qvar asthma inhalers.

Americas

Astellas accuses Cipla of infringing overactive bladder patent

7 June 2018 Pharmaceutical company Astellas Pharma has filed a patent infringement claim against India-based Cipla over a drug for treating an overactive bladder.

Big Pharma

Cipla loses fightback over diarrhoea antibiotic

More on this story

Americas

Teva sues Cipla over generic asthma inhalers

11 August 2020 Israeli drug manufacturer Teva Pharmaceuticals is suing India-based Cipla to block the launch of generic Qvar asthma inhalers.

Americas

Astellas accuses Cipla of infringing overactive bladder patent

7 June 2018 Pharmaceutical company Astellas Pharma has filed a patent infringement claim against India-based Cipla over a drug for treating an overactive bladder.

Big Pharma

Cipla loses fightback over diarrhoea antibiotic